To treat or not to treat? Different people respond in different ways to learning they have lesions that may or may not develop into threatening cancers. Charlotte Huff talks to ‘patients’, doctors and psychologists about [more]
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid delaying too [more]
A new model of active surveillance (AS) for patients with low-risk prostate cancer proved to be effective in helping clinicians to appropriately select and follow patients preventing the risk of overtreatment, according to the results [more]